Revolution Medicines (RVMD) Change in Acquisitions & Divestments (2019 - 2026)

Revolution Medicines' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $383.9 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 22.81% year-over-year to $383.9 million in Q1 2026; TTM through Mar 2026 was -$107.1 million, a 364.59% decrease from a year earlier, with the FY2025 full-year figure at $6.4 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments grew to $383.9 million in Q1 2026 per RVMD's latest filing, from -$491.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.3 billion in Q3 2024 and bottomed at -$1.3 billion in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $157.7 million (2022), against an average of $114.3 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 415.76% in 2024; the steepest drop was 1010.83% in 2024.
• Year by year, Change in Acquisitions & Divestments stood at $156.1 million in 2022, then retreated by 9.34% to $141.5 million in 2023, then plunged by 1010.83% to -$1.3 billion in 2024, then soared by 61.91% to -$491.0 million in 2025, then soared by 178.19% to $383.9 million in 2026.
• Per Business Quant, the three latest RVMD Change in Acquisitions & Divestments figures stand at $383.9 million (Q1 2026), -$491.0 million (Q2 2025), and $497.4 million (Q1 2025).